Acuta Capital Partners as of March 31, 2025
Portfolio Holdings for Acuta Capital Partners
Acuta Capital Partners holds 34 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ocular Therapeutix (OCUL) | 10.4 | $8.9M | 1.2M | 7.33 | |
| Insmed Com Par $.01 (INSM) | 9.4 | $8.1M | 106k | 76.29 | |
| Tourmaline Bio (TRML) | 7.5 | $6.5M | 427k | 15.21 | |
| Aadi Bioscience (WHWK) | 7.0 | $6.1M | 3.4M | 1.78 | |
| Enliven Therapeutics (ELVN) | 6.1 | $5.2M | 265k | 19.68 | |
| Trevi Therapeutics (TRVI) | 5.7 | $4.9M | 786k | 6.29 | |
| Soleno Therapeutics (SLNO) | 5.6 | $4.8M | 67k | 71.45 | |
| Argenx Se Sponsored Adr (ARGX) | 4.8 | $4.2M | 7.0k | 591.87 | |
| Ascendis Pha- Sponsored Adr (ASND) | 4.2 | $3.6M | 23k | 155.86 | |
| Praxis Precision Medicines I (PRAX) | 3.8 | $3.3M | 87k | 37.87 | |
| Cidara Therapeutics Com New (CDTX) | 3.1 | $2.7M | 126k | 21.54 | |
| Oculis Holding Ordinary Shares (OCS) | 2.8 | $2.4M | 125k | 19.03 | |
| Revolution Medicines (RVMD) | 2.7 | $2.4M | 67k | 35.36 | |
| Liquidia Corporation Com New (LQDA) | 2.6 | $2.3M | 154k | 14.75 | |
| Bright Minds Biosciences Com New (DRUG) | 2.5 | $2.2M | 60k | 36.07 | |
| Helix Acquisition Corp Ii Cl A Ord Shs (HLXB) | 2.5 | $2.1M | 187k | 11.30 | |
| Merck & Co (MRK) | 2.4 | $2.1M | 23k | 89.76 | |
| Surrozen Com New (SRZN) | 2.3 | $2.0M | 170k | 11.66 | |
| Edgewise Therapeutics (EWTX) | 2.2 | $1.9M | 86k | 22.00 | |
| Mereo Biopharma Group Pl- Spon Ads (MREO) | 2.1 | $1.8M | 792k | 2.25 | |
| Unicycive Therapeutics | 1.6 | $1.4M | 2.4M | 0.57 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 1.4 | $1.2M | 9.6k | 124.15 | |
| Verastem Com New (VSTM) | 1.2 | $1.1M | 176k | 6.03 | |
| Gilead Sciences (GILD) | 1.2 | $1.0M | 9.3k | 112.05 | |
| Terns Pharmaceuticals (TERN) | 1.0 | $899k | 326k | 2.76 | |
| Zymeworks Del (ZYME) | 0.9 | $815k | 69k | 11.91 | |
| Ultragenyx Pharmaceutical (RARE) | 0.9 | $771k | 21k | 36.21 | |
| Verve Therapeutics (VERV) | 0.9 | $744k | 163k | 4.57 | |
| Rocket Pharmaceuticals (RCKT) | 0.6 | $556k | 83k | 6.67 | |
| Rapport Therapeutics (RAPP) | 0.2 | $165k | 16k | 10.03 | |
| Forte Biosciences Com New (FBRX) | 0.2 | $143k | 19k | 7.76 | |
| Artiva Biotherapeutics (ARTV) | 0.2 | $136k | 46k | 3.00 | |
| Nuvation Bio Inc -cw27 *w Exp 07/07/2027 (NUVB.WS) | 0.0 | $18k | 91k | 0.19 | |
| Imara Inc Cvr | 0.0 | $0 | 116k | 0.00 |
